Applied DNA Sciences News

S-1: General form for registration of securities under the Securities Act of 1933

Nov 19 06:21 ET

SC 13G: Statement of acquisition of beneficial ownership by individuals-Anson Funds Management LP(9.9%),Anson Management GP LLC(9.9%), etc.

Nov 14 17:52 ET

PRE 14A: Preliminary proxy statements relating to merger or acquisition

Nov 14 17:03 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bruce Grossman(Less than 1%)

Nov 13 16:20 ET

8-K: Current report

Nov 13 11:27 ET

8-K: Current report

Nov 7 16:38 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AMH Equity LLC(0.0%),Leviticus Partners, L.P.(0.0%)

Nov 7 10:13 ET

D: Filing D

Nov 6 16:33 ET

424B5: Prospectus

Oct 31 06:11 ET

8-K: Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

Oct 31 06:06 ET

SC 13G: Statement of acquisition of beneficial ownership by individuals-AMH Equity LLC(9.71%),Leviticus Partners, L.P.(9.71%)

Oct 2 16:39 ET

8-K: Poll Results of 2024 Stockholders Meeting

Sep 30 16:53 ET

S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Sep 30 16:38 ET

Applied DNA Sciences | 8-K: Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

Sep 18 09:07 ET

DEFA14A: Others

Aug 21 09:50 ET

DEF 14A: Definitive information statements

Aug 21 09:45 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AMH Equity LLC(0.00%),Leviticus Partners, L.P.(0.00%)

Aug 19 12:17 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AMH Equity LLC(8.41%),Leviticus Partners, L.P.(8.41%)

Aug 9 09:32 ET

8-K: Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results

Aug 8 16:21 ET

10-Q: Q3 2024 Earnings Report

Aug 8 16:19 ET